PharmaCorp Rx Stock

PharmaCorp Rx EPS

The Earnings per Share (EPS) of PharmaCorp Rx (PCRX.V) as of Sep 5, 2026 is -0.01 CAD. In the previous year, Earnings per Share (EPS) was -0.01 CAD — a change of 5.98% (lower).

EPS

-0.01CAD

YoY

5.98%

Last updated:

Earnings per Share (EPS) of PharmaCorp Rx is 2026 -0.01 CAD. Earnings per Share (EPS) of PharmaCorp Rx was 2025 -0.01 CAD. It decreases by 5.98% lower compared to the previous year.

The PharmaCorp Rx EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
-0.00 CAD
Jan 1, 2022
-0.02 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.01 CAD
Jan 1, 2026 (e)
0.01 CAD
Jan 1, 2027 (e)
0.03 CAD
The PharmaCorp Rx EPS history
YEAREPSYoY
est0.03CAD+200.00%
est0.01CAD-180.68%
-0.01CAD+5.98%
-0.01CAD-26.40%
-0.02CAD+2,363.15%
-0.00CAD—
Access this data via the Eulerpool API
Get Free API Key

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? PharmaCorp Rx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCorp Rx stock

Earnings per Share (EPS) of PharmaCorp Rx is -0.01 CAD in 2026.

Earnings per Share (EPS) of PharmaCorp Rx changed from -0.01 CAD to -0.01 CAD, representing a 5.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API
Get Free API Key

Income Statement — PharmaCorp Rx

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PharmaCorp Rx